A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/GFI117PMID 16188901
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.

  2005cited by this paper
• Predictors of Relapse and Treatment Resistance in Antineutrophil Cytoplasmic AntibodyAssociated Small-Vessel Vasculitis

  2005cited by this paper
• Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis.

  2004cited by this paper
• Sequential therapies for proliferative lupus nephritis.

  2004cited by this paper
• Churg–Strauss syndrome: successful treatment with mycophenolate mofetil

  2004cited by this paper
• A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

  2003cited by this paper
• Control of a relapse and induction of long-term remission of Wegener's granulomatosis by cyclosporine.

  2002cited by this paper
• Comparison of the Effects of Tacrolimus and Cyclosporine on the Pharmacokinetics of Mycophenolic Acid

  2001cited by this paper
• Update on the European Vasculitis Study Group trials

  2001cited by this paper
• Effect of Cyclosporine Withdrawal on Mycophenolic Acid Pharmacokinetics in Kidney Transplant Recipients With Deteriorating Renal Function: Preliminary Report

  2001cited by this paper
• Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.

  2000cited by this paper
• Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis.

  2000cited by this paper
• Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis

  2000cited by this paper
• A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance.

  1999cited by this paper
• Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement.

  1999cited by this paper
• Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis.

  1999cited by this paper
• Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis

  1996cited by this paper
• Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

  1996cited by this paper
• Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

  1996influential reference
• Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.

  1996cited by this paper
• Practical clinical pharmacology and drug interactions of low-dose methotrexate therapy in rheumatoid arthritis.

  1995cited by this paper
• Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

  1994cited by this paper
• Therapy of rheumatoid arthritis with mycophenolate mofetil.

  1993cited by this paper
• Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.

  1990cited by this paper
• Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety.

  1987cited by this paper
• Cyclophosphamide therapy of severe systemic necrotizing vasculitis.

  1979cited by this paper

• Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden

  2025cites this paper
• Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden

  2025cites this paper
• Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis.

  2025cites this paper
• Pauci‐immune necrotizing glomerulonephritis in a 24‐year‐old female with negative ANCA antibodies: A rare case report

  2024cites this paper
• A Case of Cutaneous Vasculitis in the Setting of Systemic Lupus Erythematosus and Cocaine Use

  2023cites this paper
• Expert Perspective: Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

  2022cites this paper
• The Role of Mycophenolate Mofetil for the Induction of Remission in ANCA-Associated Vasculitis: A Meta-Analysis

  2021cites this paper
• Granulomatosis with Polyangiitis

  2021cites this paper
• Mycophenolates

  2021cites this paper
• Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: A systematic review and meta-analysis.

  2021cites this paper
• Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody-associated vasculitis—a meta-analysis

  2020cites this paper
• Part II: Retiform Pupura: Workup and Therapeutic Considerations in Select Conditions.

  2020cites this paper
• Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Randomized, Controlled Trial.

  2019cites this paper
• The role of mycophenolate in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis

  2019cites this paper
• Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Evolving Concepts in Treatment

  2018cites this paper
• Pauci-Immune Vasculitides with Kidney Involvement

  2018cites this paper
• Chapter 2 Pauci-Immune Vasculitides with Kidney Involvement

  2018cites this paper
• S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden

  2017cites this paper
• Consequences of disease and treatment in ANCA-associated vasculitis

  2017influential citation
• S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden

  2017influential citation
• Treatment of ANCA-associated systemic vasculitis

  2017cites this paper
• Orbital inflammatory disease management

  2016cites this paper
• Treatment of renal ANCA-associated vasculitides.

  2016cites this paper
• Long-term outcomes in antineutrophil cytoplasmic autoantibody–positive eosinophilic granulomatosis with polyangiitis patients with renal involvement: a retrospective study of 14 Chinese patients

  2016cites this paper
• Long-term outcome of mycophenolate mofetil treatment for patients with microscopic polyangiitis: an observational study in Chinese patients

  2016cites this paper
• The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western Countries

  2015cites this paper
• Use of mycophenolate in ANCA-associated renal vasculitis: 13 years of experience at a university hospital.

  2015cites this paper
• Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab.

  2015cites this paper
• [Mycophenolate mofetil--20 years of experience in treatment of rheumatic diseases].

  2015cites this paper
• Mycophenolate mofetil in patients with anti‐neutrophil cytoplasmic antibody‐associated vasculitis: a prospective pharmacokinetics and clinical study

  2014cites this paper
• Treatment of ANCA-associated vasculitis

  2014cites this paper
• Current and future prospects in the management of granulomatosis with polyangiitis (Wegener’s granulomatosis)

  2014cites this paper
• Treatment of ANCA-associated vasculitis: new therapies and a look at old entities.

  2014cites this paper
• Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease

  2014cites this paper
• Assessment of the Birmingham vasculitis activity score in patients with MPO-ANCA-associated vasculitis: sub-analysis from a study by the Japanese Study Group for MPO-ANCA-associated vasculitis

  2013cites this paper
• Personalisierte Medizin in der Auswahl konventioneller Immunsuppressiva und „disease modifying anti-rheumatic drugs“

  2013cites this paper
• Seven clinical conundrums in the treatment of ANCA-associated vasculitis.

  2013influential citation
• Assessment of the Birmingham vasculitis activity score in patients with MPO-ANCA-associated vasculitis: sub-analysis from a study by the Japanese Study Group for MPO-ANCA-associated vasculitis

  2013cites this paper
• Personalisierte Medizin in der Auswahl konventioneller Immunsuppressiva und "disease modifying anti-rheumatic drugs"

  2013cites this paper
• Novel Therapies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

  2012cites this paper
• The health resource utilization and economic burden of systemic autoimmune rheumatic diseases

  2012influential citation
• 58 – Diffuse Alveolar Hemorrhage in Children

  2012cites this paper
• Historia del tratamiento de las vasculitis primarias History of treatment of primary vasculitis

  2012cites this paper
• Cryoglobulinemic vasculitis in systemic sclerosis successfully treated with mycophenolate mofetil

  2012cites this paper
• Pharmacological Therapy for Wegener’s Granulomatosis

  2012cites this paper
• Historia del tratamiento de las vasculitis primarias

  2012cites this paper
• Treatment of ANCA-Associated Vasculitis, Where to Go?

  2012cites this paper
• Neues in der Immunsuppression von Vaskulitiden

  2012cites this paper
• The Molecular Biology and Treatment of Systemic Vasculitis in Children

  2012cites this paper
• Treatment of severe cutaneous small-vessel vasculitis with mycophenolate mofetil.

  2012cites this paper
• Wegener's Granulomatosis Mimicking Pulmonary Tuberculosis

  2012cites this paper
• The 2010 nephrology quiz and questionnaire: part 2.

  2011influential citation
• Effects of Mycophenolate Mofetil Combined with Corticosteroids for Induction Therapy of Microscopic Polyangiitis

  2011cites this paper
• Wegener Granulomatosis, Polyarteritis Nodosa, Microscopic Polyangiitis, Behçet Disease and Relapsing Polychondritis

  2011cites this paper
• Mycophenolate mofetil (MMF) treatment efficacy in children with primary and secondary glomerulonephritis

  2011cites this paper
• Wegener's granulomatosis.

  2011cites this paper
• The 2010 Nephrology Quiz and Questionnaire

  2011cites this paper
• Wegener’s Granulomatosis of the Orbit: A Review of Clinical Features and Updates in Diagnosis and Treatment

  2011cites this paper
• Prolonged Fever with Massive Hemoptysis

  2011cites this paper
• Life-Threatening Presentations of ANCA-Associated Vasculitis

  2011cites this paper
• Myeloperoxidase-specific plasma cell depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-induced glomerulonephritis.

  2011cites this paper
• Drug Induced Small Vessel Vasculitis

  2011cites this paper
• RPGN - Clinical Features, Treatment and Prognosis

  2011cites this paper
• Immunosuppressive and Cytotoxic Therapy: Pharmacology, Toxicities, and Monitoring

  2011cites this paper
• Difficult asthma and Churg‐Strauss‐like syndrome: A cautionary tale

  2011cites this paper
• Wegener Granulomatosis (Granulomatosis with Polyangiitis): Evolving Concepts in Treatment

  2011influential citation
• Updates in Treatment of ANCA-associated Vasculitis

  2010cites this paper
• ANCA negative pauci-immune glomerulonephritis with systemic involvement

  2010cites this paper
• ANCA-Associated Small Vessel Vasculitis: Clinical and Therapeutic Advances

  2010cites this paper
• Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.

  2010cites this paper
• An overview of pharmacotherapy for anti-neutrophil cytoplasmic antibody-associated vasculitis.

  2010cites this paper
• Recent advances to achieve remission induction in antineutrophil cytoplasmic antibody-associated vasculitis

  2010cites this paper
• Population Pharmacokinetics of Mycophenolic Acid and Metabolites in Patients With Glomerulonephritis

  2010cites this paper
• Clinical manifestations and treatment of Wegener's granulomatosis.

  2010cites this paper
• Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.

  2010cites this paper
• Treatment of Primary Systemic Vasculitis with the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolic Acid

  2010cites this paper
• [Treatment of ANCA-associated systemic vasculitis].

  2010cites this paper
• Treatment of ANCA-associated systemic vasculitis

  2010influential citation
• VASCULARITES DES PETITS VAISSEAUX ASSOCIÉES AUX ANCA: LE POINT SUR LES TRAITEMENTS

  2010cites this paper
• Chapter 16 – Management of Medium and Small Vessel Vasculitis, Including the Antineutrophil Cytoplasmic Antibody–Associated Diseases

  2010cites this paper
• CHAPTER 24 – Renal and Systemic Vasculitis

  2010cites this paper
• Tratamiento de las vasculitis ANCA positivas

  2010cites this paper
• Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease.

  2009cites this paper
• Review article: Progress of treatment in ANCA‐associated vasculitis

  2009cites this paper
• Respiratory Disease Antibody-Associated Vasculitides and Antineutrophil Cytoplasmic

  2009cites this paper
• ANCA-associated vasculitis: from bench research to novel treatments

  2009cites this paper
• Mycophenolate mofetil therapy in a child with Churg–Strauss syndrome

  2009cites this paper
• Granulomatosis de Wegener, abordaje diagnóstico y terapéutico

  2009cites this paper
• ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy.

  2009cites this paper
• Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement.

  2009cites this paper
• [Wegener's granulomatosis: diagnosis and treatment].

  2009cites this paper
• Autoimmunvaskulitiden

  2009cites this paper
• Newer therapies for vasculitis.

  2009cites this paper
• Nonsystemic vasculitic neuropathy: update on diagnosis, classification, pathogenesis, and treatment.

  2009cites this paper
• Condicionantes epidemiológicos de salud y su relación con rendimiento escolar en el primer año de la carrera de medicina

  2009cites this paper
• Advances in childhood vasculitis

  2009cites this paper
• Influence of Clinical and Demographic Variables on Mycophenolic Acid Pharmacokinetics in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

  2009cites this paper
• Small vessel vasculitis

  2009cites this paper
• 維持透析導入後も18年間MPO-ANCA高値が持続し，肺胞出血で再燃した顕微鏡的多発血管炎の1例

  2009cites this paper
• Wegener’s granulomatosis: an update on diagnosis and therapy

  2008cites this paper